Research & analysis only — not investment advice

Atrium Therapeutics, Inc. (RNA)

US equity research on AlphaOS

Atrium Therapeutics, Inc. operates in unknown sector.

Atrium Therapeutics, Inc. key market context on AlphaOS includes Market capitalization: $217.07M; Recent price: $12.69. Figures update as market data and SEC filings are ingested.

Use this RNA research hub for earnings transcripts, SEC filings, opportunity scoring, news, and knowledge-graph relationships. Content is for research and education only — not investment advice.

Key facts

Market cap:
$217.07M

Interactive charts, filings, and live quotes load below. Research & analysis only — not investment advice.

Intelligence coverage: 35%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

RNA

Atrium Therapeutics, Inc.

$12.69Jun 18, 2026

AI confidence 47% · prior close shown (market closed)

Filing insights

Loading SEC filing intelligence…

SEC filings

10-K, 10-Q, 8-K, 20-F, 6-K from EDGAR — HTML & PDF stored in GCS

No filings yet

Ingest recent SEC filings for RNA to enable RAG search and AI risk analysis.